5.1 Ferroptosis inducers FINs can be categorized into four types based on diverse mechanisms (Table 2) (Nie et al., 2018)
FDA approved GLP-1: The following GLP-1 medications are currently on the market and approved by the FDA: Byetta, Bydureon (exenatide) Trulicity (dulaglutide), Victoza, Saxenda, Xultophy (liraglutide) Ozempic, Rybelsus, Wegovy (semaglutide) Mounjaro, Zepbound (tirzepatide) Although weight loss is a side effect of all GLP-1 medications, the FDA has only approved Wegovy, Saxenda, and Zepbound for this usage
The treatment of AUD includes psychosocial and pharmacological interventions [5]
K.ChengJ.AccursoE
Ran Q, Liang H, Gu M, Qi W, Walter CA, Roberts LJ 2nd, et al
Serious problems are mostly linked to unsupervised use, buying the drug without a prescription, or pushing the dose up too fast